U.S. Transdermal Drug Delivery Market

U.S. Transdermal Drug Delivery Market published by Frost & Sullivan in August, 2006. This report price starts from US $ 6000.

Introduction

Abstract

This Frost & Sullivan research service entitled U.S. Transdermal Drug Delivery Market provides pipeline analysis, forecasts, and technology overviews. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, pain management, vaccines, and sexual dysfunction.

This analysis is available through our Pharmaceutical and Clinical Diagnostics Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1. Executive Summary

• 1. Executive Summary
  • 1. Executive Summary

2. Market Introduction

• 1. Research Scope and Methodology
  • 1. Scope and Segmentation
  • 2. Methodology
• 2. Market Overview
  • 1. Market Engineering Measurements
  • 2. Technology Overview
  • 3. Passive Transdermal Technology
  • 4. Active Transdermal Technology
  • 5. Disease Targets and Applications
  • 6. Challenges and Strategies
  • 7. Market Drivers
• 3. Product Analysis
  • 1. Pain Management
  • 2. Hormone
  • 3. CNS
  • 4. Cardiovascular
  • 5. Others
  • 6. Pipeline Overview

3. Competitive Analysis

• 1. Competitive Analysis
  • 1. Competitive Structure
  • 2. Licensing and Partnership Strategies
• 2. Forecasts and Trends
  • 1. Total Market
  • 2. Pain Management
  • 3. Hormone
  • 4. Central Nervous System
  • 5. Cardiovascular
  • 6. Others
  • 7. Market Share Analysis

4. Frost & Sullivan Awards

• 1. Frost & Sullivan Awards
  • 1. Company of the Year
  • 2. Entrepreneurial Company of the Year
  • 3. Business Development Strategy Leadership of the Year

5. Appendix

• 1. Decision Support Databases
  • 1. Prevalence of Parkinson's Disease
  • 2. Prevalence of Alzheimer's Disease
  • 3. Pharmaceutical R&D Expenditure
  • 4. Total Female Population
  • 5. Fertility Rate per Women

Related Reports